In March 2025, SYLKE® raised a $10.03 million Series A at a $150 million pre-money valuation.
Latest Stories
SYLKE® Receives the 2025 AAHKS Industry Innovation Award
October 24, 2025 SYLKE® Skin Closure was named a recipient of the Industry Innovation Award at the 2025 American Association of Hip and Knee Surgeons Annual Meeting. At the 2025 AAHKS Annual Meeting in Dallas, Texas, Sylke, Inc. was named...
Read moreabout SYLKE® Receives the 2025 AAHKS Industry Innovation Award
SYLKE® Launches Global Relief: Charitable Use Program
Our charitable use program that partners with nonprofits and frontline healthcare teams to deliver SYLKE® Skin Closure dressings where they’re needed most.
Read moreabout SYLKE® Launches Global Relief: Charitable Use Program
SYLKE® Awarded Breakthrough Technology Designation with Premier, Inc.
July 15, 2025 The designation provides Premier member hospitals and health systems with access to SYLKE® Skin Closure through one of the nation's largest group purchasing organizations. SYLKE® Skin Closure has been awarded a Breakthrough Technology Designation with Premier, Inc.,...
Read moreabout SYLKE® Awarded Breakthrough Technology Designation with Premier, Inc.
Share:
SYLKE® Named an Allure 2024 Best of Beauty Breakthrough
SYLKE® Awarded Breakthrough Technology Designation with Premier, Inc.